ST
CTIC

Spot Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Spot Trading’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,110
Closed -$14K – 4499
2015
Q4 		$14K Hold
1,110
– – ﹤0.01% 3290
2015
Q3 		$16K Hold
1,110
– – ﹤0.01% 3552
2015
Q2 		$22K Hold
1,110
– – ﹤0.01% 3454
2015
Q1 		$20K Buy
+1,110
New +$25K ﹤0.01% 3506
2013
Q3 		– Sell
-2,500
Closed -$26K – 4803
2013
Q2 		$26K Buy
+2,500
New +$29.3K ﹤0.01% 3825

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Spot Trading's CTIC Position: Q1 2016 in Review

Spot Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2016, closing a stake of 1,318 shares — an estimated $16K sold.

Spot Trading first reported a position in CTIC in Q2 2013 and held it in 5 quarters. The position peaked at $26K in Q2 2015. 80 funds tracked by Wall St. Rank hold CTIC as of Q1 2016.

  • Spot Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 1,318 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2016, an estimated $16K.
  • Spot Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 5 quarters.
  • Spot Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $26K in Q2 2015.
  • 80 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.